Leerink Partnrs Reduces Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at Leerink Partnrs dropped their Q1 2025 earnings estimates for Henry Schein in a note issued to investors on Tuesday, February 25th. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings of $1.14 per share for the quarter, down from their prior forecast of $1.19. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q3 2025 earnings at $1.26 EPS.

HSIC has been the subject of a number of other research reports. Mizuho assumed coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. Wells Fargo & Company assumed coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective for the company. Barrington Research reissued an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a report on Wednesday. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Stock Down 0.6 %

HSIC stock opened at $72.12 on Friday. The stock has a fifty day moving average of $74.35 and a 200-day moving average of $72.42. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The company has a market capitalization of $8.99 billion, a price-to-earnings ratio of 29.68, a PEG ratio of 2.13 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the company posted $0.66 earnings per share.

Institutional Trading of Henry Schein

Large investors have recently modified their holdings of the business. Palestra Capital Management LLC bought a new stake in Henry Schein during the fourth quarter valued at approximately $182,988,000. Lyrical Asset Management LP purchased a new stake in shares of Henry Schein during the 4th quarter valued at $126,655,000. Norges Bank bought a new stake in shares of Henry Schein during the 4th quarter worth $103,301,000. Steadfast Capital Management LP grew its position in Henry Schein by 254.2% in the fourth quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock worth $113,336,000 after acquiring an additional 1,175,408 shares in the last quarter. Finally, ING Groep NV bought a new position in Henry Schein in the third quarter valued at $63,226,000. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.